MEDTRONIC ($MDT) posted quarterly earnings results on Wednesday, May 21st. The company reported earnings of $1.62 per share, beating estimates of $1.59 by $0.03. The company also reported revenue of $8,927,000,000, beating estimates of $8,904,567,555 by $22,432,445.
You can see Quiver Quantitative's $MDT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MEDTRONIC Insider Trading Activity
MEDTRONIC insiders have traded $MDT stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MDT stock by insiders over the last 6 months:
- BRETT A. WALL (EVP & Pres Neuroscience) has made 0 purchases and 3 sales selling 22,287 shares for an estimated $1,911,368.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MEDTRONIC Hedge Fund Activity
We have seen 1,118 institutional investors add shares of MEDTRONIC stock to their portfolio, and 1,013 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 8,425,239 shares (-68.0%) from their portfolio in Q1 2025, for an estimated $757,091,976
- CAPITAL RESEARCH GLOBAL INVESTORS added 8,363,931 shares (+25.2%) to their portfolio in Q1 2025, for an estimated $751,582,839
- FISHER ASSET MANAGEMENT, LLC removed 5,161,053 shares (-85.0%) from their portfolio in Q1 2025, for an estimated $463,772,222
- CAPITAL WORLD INVESTORS added 4,989,195 shares (+inf%) to their portfolio in Q1 2025, for an estimated $448,329,062
- BOSTON PARTNERS added 3,809,450 shares (+122.8%) to their portfolio in Q1 2025, for an estimated $342,317,177
- AMERIPRISE FINANCIAL INC added 3,461,221 shares (+28.8%) to their portfolio in Q1 2025, for an estimated $311,025,319
- JPMORGAN CHASE & CO added 3,201,226 shares (+9.3%) to their portfolio in Q1 2025, for an estimated $287,662,168
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MEDTRONIC Analyst Ratings
Wall Street analysts have issued reports on $MDT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 03/04/2025
- Bernstein issued a "Outperform" rating on 01/08/2025
To track analyst ratings and price targets for MEDTRONIC, check out Quiver Quantitative's $MDT forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
